21st Century Biochemicals LLC

TANGENX TangenX Technology Corporation is primarily engaged in the development, production and commercialization of innovative tangential flow filtration ( TFF ) membrane products for the bio-pharmaceutical industry. The TangenX management team has extensive experience in membrane product development as well as purification process development and scale up.

HelixBind Inc., based in Boxborough, MA, is at the forefront of revolutionizing diagnostics for bloodstream infections through its innovative platform that delivers faster, more accurate, and informative microbiology results. By enabling precise identification of invasive infections, HelixBind aims to support clinicians in developing personalized antimicrobial therapies, ultimately improving patient outcomes and combating the rise of antimicrobial resistance. Addressing the urgent challenge of sepsis—which accounts for 1.7 million cases annually in the US and over 30 million globally—HelixBind significantly reduces the turnaround time for diagnostic results. Their technology provides key insights in just four hours, compared to traditional blood cultures that take 2-3 days, allowing healthcare providers to initiate effective treatment promptly. Generated from the website

21st Century Biochemicals, based in Marlborough, MA, specializes in custom antibodies and peptides. Their services range from peptide synthesis to antibody production and phosphospecific polyclonal antibody production. The company also offers MS check services for those in need of mass spectrometry analysis. Customers can learn more about their services and special offers by visiting the company's website. Generated from their available business information